Levomethorphane [Inn-French]
Brand names,
Levomethorphane [Inn-French]
Analogs
Levomethorphane [Inn-French]
Brand Names Mixture
Levomethorphane [Inn-French]
Chemical_Formula
C18H25NO
Levomethorphane [Inn-French]
RX_link
No information avaliable
Levomethorphane [Inn-French]
fda sheet
Levomethorphane [Inn-French]
msds (material safety sheet)
Levomethorphane [Inn-French]
Synthesis Reference
No information avaliable
Levomethorphane [Inn-French]
Molecular Weight
271.397 g/mol
Levomethorphane [Inn-French]
Melting Point
No information avaliable
Levomethorphane [Inn-French]
H2O Solubility
74.7 mg/L
Levomethorphane [Inn-French]
State
Solid
Levomethorphane [Inn-French]
LogP
4.323
Levomethorphane [Inn-French]
Dosage Forms
Capsule; Liquid; Lozenge; Syrup; Tablet
Levomethorphane [Inn-French]
Indication
For treatment and relief of dry cough.
Levomethorphane [Inn-French]
Pharmacology
Dextromethorphan suppresses the cough reflex by a direct action on the cough center in the medulla of the brain. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity.
Levomethorphane [Inn-French]
Absorption
Rapidly absorbed from the gastrointestinal tract.
Levomethorphane [Inn-French]
side effects and Toxicity
No information avaliable
Levomethorphane [Inn-French]
Patient Information
No information avaliable
Levomethorphane [Inn-French]
Organisms Affected
Humans and other mammals